MedPath

Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis

Not Applicable
Completed
Conditions
Contact Dermatitis
Interventions
Device: Tetrix
Device: Placebo
Registration Number
NCT00646867
Lead Sponsor
Coria Laboratories, Ltd.
Brief Summary

To determine if Tetrix Cream, when applied to the skin lesions on patients with contact dermatitis, improves the symptoms of burning and itching.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  1. Normal subjects with sensitivity to nickel
  2. Subjects with hand eczema
Exclusion Criteria

under 18 years of age

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1TetrixExperimental
2PlaceboPlacebo
Primary Outcome Measures
NameTimeMethod
Improvement in symptoms of burning and itching.after 14 days of treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dermatology Specialists, LLC

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath